1/31
Looks like no tags are added yet.
-overexpression of transmembrane human epidermal growth factor receptor protein(HER2) is seen in 25% to 30% of patients
Trastuzumab
Tyrosine kinase activity is mediated by ______ of signaling proteins
phosphorylation
-binds to HER2 sites
-inhibits proliferation of cells that overexpress the HER2 protein
-when bound to HER2 it blocks downstream signaling pathways
-induces antibody-dependent cytotoxicty
-prevents the release of HER2
Trastuzumab(Herceptin)
Adverse effects include:
-congestive heart failure
-infusion related fever and chills
-pulmonary toxicity
-headache
Trastuzumab(herceptin)
What extreme caution should be taken with trastuzumab?
patients with preexisting cardiac dysfunction
-genetically engineered against the CD20 antigen that is on the surface of normal and malignant B lymphocytes
Rituximab
The Fab region of _____ binds to the CD20 antigen on the B lymphocytes
rituximab
-induces complement dependent cytotoxicity(CDC) and antibody dependent cell mediated cytotoxicity(ADCC) of B cells
rituximab
Adverse effects of what drug?
-hypotension
-bronchospasm
-angioedema
rituximab
What should be treated with rituximab to prevent angioedema?
diphenhydramine and acetaminophen
-approved for metastatic colorectal cancer
-given with 5-FU
-stops vascular endothelial growth factor from forming new blood vessels
bevacizumab(Avastin)
-treats KAS mediated colorectal head and neck cancers
Cetuximab(Erbitux) and Panitumumab(Vectibix)
-targets the EGFR on the surface of cancer cells
-appearance of rash seen as a positive sign of therapy
Cetuximab(Erbitux) and Panitumumab(Vectibix)
-targets BCR-ABL gene translocation(Phil chromosome) abnormal tyrosine kinase
Imatinib, dasatinib, and nilotinib
-tyrosine kinase inhibitors
-targets BCR-ABL tyrosine kinase which is present in almost all(95%) Chronic Myelogenous Leukemia patients
imatinib
Adverse effects include:
-fluid retention
-QT prolongation
Imatinib
-BRAF mutation abnormal tyrosine kinase that is always "on"
-occurs in 50% of melanoma patients
BRAF inhibitors
What are the BRAF inhibitors?
-Vemurafenib
-Dabrafenib
Must be BRAF V600E or V600K mutation positive to use
Vemurafenib and Dabrafenib
-inhibits MEK, a cell signaling protein downstream from RAF
Trametinib and Cobimetinib
-MEK 1 and 2 inhibitors
-used in combination with BRAF inhibitors in patients with BRAF V600E or V600K mutation
MEK 1 and 2 inhibitors
Adverse effects include:
-hypertension
-HF
-hepatotoxicity
-skin rash
-NVD
-myelosuppression
-hand-food syndrome
Trametinib and Cobimetinib
What drugs cause new malignancies, such as squamous cell carcinoma and basal cell carcinoma and QT prolongation and photosensitivity?
Vemurafenib and Dabrafenib
-EGFR inhibitor
-used to treat non-small cell lung cancer and pancreatic cancer
-extensive metabolism in the liver
Erlotinib
-oral serine/threonine and TK inhibitor
-used to treat renal cell carcinoma
Sorafenib and Sunitinib
-block angiogenesis and kill abnormal cells in bone marrow
-need the REMS program that causes severe birth defects
lenalidmide and pomalidomide and Thalidomide
-immunomodulators
-PD-1 inhibitors that increase T-cell activation which helps recognize cancer cells as foreign or non-self
-activates the immune system(antitumor response)
Pembrolizumab
-a human MoAB that blocks cytotoxic T-lymph. antigen(CTLA-4)
-approved to treat metastatic melanoma
-acts as a negative regulator of T-cell function
ipilimumab
-enhanced T-cell stimulation, proliferation, and antitumor activity
-it can take 3 months or longer to see a response in patients with melanoma
Ipilimumab
Adverse effects of what drug?
-autoimmune inflammatory toxicities
-enterocolitis, diarrhea
-hepatitis
-dermatitis skin rash
-neuropathy
Ipilimumab
-anti-CTLA-4 human IgG1
-activating the immune response(antitumor response)
-used in metastatic melanoma as single agent or in combination with Nivolumab
Ipilimumab
-inhibit proteasomes which help to regulate intracellular protein homeostasis by inhibiting cell cycle progression and inducing apoptosis
Bortezomib and Carfilzomib